Dp. Berger et al., VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) MESSENGER-RNA EXPRESSION INHUMAN TUMOR-MODELS OF DIFFERENT HISTOLOGIES, Annals of oncology, 6(8), 1995, pp. 817-825
Background: Vascular endothelial growth factor (VEGF) is a polypeptide
with specific effects on endothelial cell growth and blood vessel per
meability. Recent studies demonstrated a key role for VEGF in tumor ne
ovascularization, which is a prerequisite for tumor proliferation and
metastasis. Materials and methods: We studied the expression of VEGF m
RNA in a panel of 65 different human tumor xenografts of various histo
logies using Northern and slot blot analyses. Analysis of vessel densi
ty was performed morphologically and after immunohistochemical stainin
g of endothelial cells. Results: High expression levels were observed
in 22/65 tumors. In melanoma, colorectal, gastric, breast and lung can
cers only single tumors showed strong expression signals, whereas 7/10
renal cell carcinoma (RCC) xenografts demonstrated high levels of VEG
F mRNA. Vessel density analysis revealed a clear correlation of VEGF m
RNA expression with vascularization in RCC (p = 0.0048). Patient survi
val time was compared for tumors showing high versus low expression va
lues. The overall 5-year survival rate was significantly lower for pat
ients with high expression of VEGF mRNA (p = 0.0306). Conclusions: The
se data support the hypothesis that tumor cells of various histologies
secrete VEGF, which acts as a paracrine factor to induce endothelial
cell proliferation and vessel formation and mediates tumor progression
.